The conservative treatment group consisted of 28/287 (9.8%) patients with MBL levels below 100 ng/ml, a cut-off generally accepted for the definition of functional MBL deficiency. This evidence concerns the gene MBL2 and hyperinsulinemic hypoglycemia, familial, 4.